EKF Introduces Hand-held Hemoglobin Analyzer with Secure POC Connectivity

DiaSpect Tm POC hemoglobin analyzer now powered by EKF Link digital connectivity solution

 

 

 

The DiaSpect POC hemoglobin analyzer now powered by EKF Link digital connectivity solution
For a high res image, please contact sarahp@alto-marketing.com

 
Cardiff, UK – 18th October 2022 – EKF Diagnostics, a global in vitro diagnostics company, announces an enhanced DiaSpect Tm. The hand-held hemoglobin analyzer now connects securely to EKF Link, the company’s own point-of-care (POC) middleware, enabling additional features including a calculated hematocrit value and data management. Available globally, the DiaSpect Tm has received an IVD CE-mark, FDA clearance and is registered in many more countries across all continents.
 
Ensuring test results are stored and accessed securely on a centralized platform, the enhanced DiaSpect Tm can now be connected to the recently released EKF Link middleware. This expands on the ever-growing list of analyzers that are compatible with the new state-of-the-art POC data management platform. EKF’s DiaSpect Tm is also now equipped with Bluetooth, internal storage for 4000 tests and QC results, as well as the capability to provide a calculated hematocrit value alongside the usual hemoglobin result.
 
Moving into a new era of POC connectivity, the DiaSpect Tm results are easily accessible from a web browser through EKF Link while being securely protected on the servers already available in most laboratories and hospitals. Patient and operator identification allow for better tracking of both staff competence and test results, and a Quality Control reminder function ensures compliance with ever tightening local regulations.
 
Enabling rapid decision making, the DiaSpect Tm simultaneously delivers hemoglobin with calculated hematocrit results in under two seconds from just 10 µL of capillary or venous blood collected in microcuvettes and inserted directly into the analyzer. This makes it extremely user-friendly requiring minimal training. In addition, no calibration is required as it is factory calibrated against the HiCN reference method, and turbidity is also measured and compensated for.
 
Commenting on the new introduction, David Wojahn, Hematology Product Manager for EKF Diagnostics, said, “Our new DiaSpect Tm will enable POC coordinators, operating rooms and screening programs to connect this fast and reliable photometric hemoglobin analyzer to Laboratory Information Systems (LIS) or Patient Information Systems (PIS) through EKF Link. Now with the EKF Link connectivity, DiaSpect Tm is an ideal POC solution enabling users to rapidly upload results from anywhere and power up their performance, delivering results directly alongside the patient or blood donor.
 
The DiaSpect Tm is an ideal POC hemoglobin analyzer as it is palm-sized, lightweight, robust and easily transportable. It can be used in any screening setting, even in challenging climatic environments. This is because its reagent-less microcuvettes have up to 2.5 years shelf life, even after opening, and are unaffected by temperature and humidity. Its ‘always-on’ technology enables professionals to start using the device immediately; and the rechargeable internal battery, which provides up to 40 days/10,000 tests continuous use, offers the flexibility of not needing a power source for weeks at a time.
 
For more information about EKF Diagnostics, please visit https://www.ekfdiagnostics.com/, follow @EKFdiagnostics on twitter, or follow EKF Diagnostics on LinkedIn.

About EKF Diagnostics Holdings plc www.ekfdiagnostics.com 
EKF is a leading global diagnostics business with custom manufacturing facilities across sites in the US, UK and Europe for a variety of life science products. EKF is focused on the following areas:
Point-of-Care
Providing a portfolio of Point-of-Care analyzers and consumables, particularly for use in the area of Hematology and Diabetes, for use in hospital and research laboratories, doctor's offices, blood banks and for in-field anemia screening programs. EKF has an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries.
Central Laboratory
Clinical chemistry, small lab analyzers, Centrifuges
Beta-Hydroxybutyrate (β-HB) LiquiColor, Glycated Albumin, Glycated Serum Protein, Nitro-tab, Procalcitonin
Life Sciences
Enzyme fermentation, Custom products and Bulk fermentation
Contract Manufacturing
Bulk formulation, Sample collection kits, Private labelling, Molecular and forensic kits
Laboratory Testing
Laboratory testing services certified under the Clinical Laboratory Improvement Amendments ("CLIA") for high complexity testing.